title: Management of acute pulmonary embolism.
authors.affiliation: Clinical Research Fellow, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield.
authors.forename: Rehan
authors.initials: R
authors.lastname: Quadery
authors.affiliation: Consultant Chest Physician in the Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield.
authors.forename: Charlie A
authors.initials: CA
authors.lastname: Elliot
authors.affiliation: Consultant Chest Physician in the Deoartment of Respiratory Medicine, Northern General Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield.
authors.forename: Judith
authors.initials: J
authors.lastname: Hurdman
authors.affiliation: Consultant Chest Physician and Clinical Director in the Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield and Honorary Professor in the Department of Pulmonary Vascular Medicine, University of Sheffield, Sheffield.
authors.forename: David G
authors.initials: DG
authors.lastname: Kiely
authors.affiliation: Consultant Haematologist in the Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield.
authors.forename: Rhona M
authors.initials: RM
authors.lastname: Maclean
authors.affiliation: Professor in the Department of Infection and Immunity, University of Sheffield, Sheffield.
authors.forename: Ian
authors.initials: I
authors.lastname: Sabroe
authors.affiliation: Consultant Haematologist in the Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield.
authors.forename: Joost J
authors.initials: JJ
authors.lastname: van Veen
authors.affiliation: Consultant Chest Physician in the Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield S10 2JF.
authors.forename: Robin
authors.initials: R
authors.lastname: Condliffe
mesh_terms: D000208:Acute Disease; D000367:Age Factors; D000553:Ambulatory Care; D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use*; D015897:Comorbidity; D000069604:Dabigatran / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000175:diagnosis / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D018570:Risk Assessment; D000069552:Rivaroxaban / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016306:Vena Cava Filters; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; D010959:Tissue Plasminogen Activator; D000069604:Dabigatran